Literature DB >> 18712385

The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT.

K Strobel1, U E Exner, K D M Stumpe, T F Hany, B Bode, K Mende, P Veit-Haibach, G K von Schulthess, Juerg Hodler.   

Abstract

OBJECTIVE: To evaluate the value of a dedicated interpretation of the CT images in the differential diagnosis of benign vs. malignant primary bone lesions with 18 fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT).
MATERIALS AND METHODS: In 50 consecutive patients (21 women, 29 men, mean age 36.9, age range 11-72) with suspected primary bone neoplasm conventional radiographs and 18F-FDG-PET/CT were performed. Differentiation of benign and malignant lesions was separately performed on conventional radiographs, PET alone (PET), and PET/CT with specific evaluation of the CT part. Histology served as the standard of reference in 46 cases, clinical, and imaging follow-up in four cases.
RESULTS: According to the standard of reference, conventional 17 lesions were benign and 33 malignant. Sensitivity, specificity, and accuracy in assessment of malignancy was 85%, 65% and 78% for conventional radiographs, 85%, 35% and 68% for PET alone and 91%, 77% and 86% for combined PET/CT. Median SUV(max) was 3.5 for benign lesions (range 1.6-8.0) and 5.7 (range 0.8-41.7) for malignant lesions. In eight patients with bone lesions with high FDG-uptake (SUV(max) >or= 2.5) dedicated CT interpretation led to the correct diagnosis of a benign lesion (three fibrous dysplasias, two osteomyelitis, one aneurysmatic bone cyst, one fibrous cortical defect, 1 phosphaturic mesenchymal tumor). In four patients with lesions with low FDG-uptake (SUV(max) < 2.5) dedicated CT interpretation led to the correct diagnosis of a malignant lesion (three chondrosarcomas and one leiomyosarcoma). Combined PET/CT was significantly more accurate in the differentiation of benign and malignant lesions than PET alone (p = .039). There was no significant difference between PET/CT and conventional radiographs (p = .625).
CONCLUSION: Dedicated interpretation of the CT part significantly improved the performance of FDG-PET/CT in differentiation of benign and malignant primary bone lesions compared to PET alone. PET/CT more commonly differentiated benign from malignant primary bone lesions compared with conventional radiographs, but this difference was not significant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712385     DOI: 10.1007/s00259-008-0876-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  40 in total

1.  Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.

Authors:  F Dehdashti; B A Siegel; L K Griffeth; M J Fusselman; D D Trask; A H McGuire; D J McGuire
Journal:  Radiology       Date:  1996-07       Impact factor: 11.105

2.  Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT.

Authors:  Suzanne L Aquino; Landon B Kuester; Victorine V Muse; Elkan F Halpern; Alan J Fischman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-03       Impact factor: 9.236

Review 3.  [Standards and diagnostic strategies in diagnosis of bone tumors and tumor-simulating lesions].

Authors:  J Freyschmidt
Journal:  Radiologe       Date:  1998-04       Impact factor: 0.635

4.  A PET study of 18FDG uptake in soft tissue masses.

Authors:  M A Lodge; J D Lucas; P K Marsden; B F Cronin; M J O'Doherty; M A Smith
Journal:  Eur J Nucl Med       Date:  1999-01

5.  PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease.

Authors:  Geoffrey S Goodin; Barry L Shulkin; Robert A Kaufman; M Beth McCarville
Journal:  AJR Am J Roentgenol       Date:  2006-10       Impact factor: 3.959

6.  Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET.

Authors:  M Schulte; D Brecht-Krauss; B Heymer; A Guhlmann; E Hartwig; M R Sarkar; C G Diederichs; A Von Baer; J Kotzerke; S N Reske
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

7.  Computed tomographic evaluation of primary osseous malignant neoplasms.

Authors:  J A Lukens; R A McLeod; F H Sim
Journal:  AJR Am J Roentgenol       Date:  1982-07       Impact factor: 3.959

8.  Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.

Authors:  Douglas S Hawkins; Joseph G Rajendran; Ernest U Conrad; James D Bruckner; Janet F Eary
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

9.  Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.

Authors:  D-S Shin; O-J Shon; S-J Byun; J-H Choi; K-A Chun; I-H Cho
Journal:  Skeletal Radiol       Date:  2008-02-29       Impact factor: 2.199

10.  Comparison of PET with CT, MRI, and conventional scintigraphy in a benign and in a malignant soft tissue tumor.

Authors:  L P Adler; H F Blair; J T Makley; M N Pathria; F Miraldi
Journal:  Orthopedics       Date:  1991-08       Impact factor: 1.390

View more
  24 in total

1.  Rapidly progressive bone destruction of the finger as first presentation of systemic metastases from lung cancer.

Authors:  Sten Myrehaug; Andrea Bezjak
Journal:  BMJ Case Rep       Date:  2010-01-13

Review 2.  F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature.

Authors:  Ty K Subhawong; Aaron Winn; Shai S Shemesh; Juan Pretell-Mazzini
Journal:  Skeletal Radiol       Date:  2017-06-12       Impact factor: 2.199

Review 3.  Advances in multimodality molecular imaging of bone structure and function.

Authors:  Floor M Lambers; Gisela Kuhn; Ralph Müller
Journal:  Bonekey Rep       Date:  2012-02-22

4.  PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact.

Authors:  Bernd Klaeser; Jakub Wiskirchen; Jan Wartenberg; Thilo Weitzel; Ralph A Schmid; Michel D Mueller; Thomas Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-03       Impact factor: 9.236

Review 5.  PET/CT in primary musculoskeletal tumours: a step forward.

Authors:  A Lakkaraju; C N Patel; K M Bradley; A F Scarsbrook
Journal:  Eur Radiol       Date:  2010-06-25       Impact factor: 5.315

6.  [Whole-body MRI and FDG-PET/CT imaging diagnostics in oncology].

Authors:  G P Schmidt; A Haug; M F Reiser; C Rist
Journal:  Radiologe       Date:  2010-04       Impact factor: 0.635

7.  The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Megumi Jinguji; Yoshihiko Fukukura; Yoshiaki Nakabeppu; Atsushi Tani; Takashi Yoshiura
Journal:  Br J Radiol       Date:  2015-09-04       Impact factor: 3.039

8.  Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.

Authors:  Rong Tian; Minggang Su; Ye Tian; Fanglan Li; Lin Li; Anren Kuang; Jiancheng Zeng
Journal:  Skeletal Radiol       Date:  2009-02-10       Impact factor: 2.199

9.  Positron emission tomography/computed tomography for osseous and soft tissue sarcomas: A systematic review of the literature and meta-analysis.

Authors:  Aikeremujiang Muheremu; Junyi Ma; Aierken Amudong; Yong Ma; Maimaitiaili Niyazi; Yong Ou; Yuan Ma
Journal:  Mol Clin Oncol       Date:  2017-07-18

10.  Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.

Authors:  Manaf H Younis; Hasan A Abu-Hijleh; Osama O Aldahamsheh; Abdulrahman Abualruz; Lukman Thalib
Journal:  Med Princ Pract       Date:  2019-12-31       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.